Skip to content

Ashwagandha, Sesame, and Rosemary Gel Vs Diclofenac Gel with Ultrasound in Back Myofascial Pain

Formulation and Comparative Efficacy of Ashwagandha, Sesame, and Rosemary Gel Vs Diclofenac Gel with Ultrasound in Back Myofascial Pain

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230202057310N12
Enrollment
110
Registered
2024-12-22
Start date
2025-01-07
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back myofascial pain syndrome. Myositis

Interventions

Intervention 1: Intervention group: Group 1: The ASR gel was applied to the affected area, followed by 10 minutes of ultrasound therapy using a 1 MHz ultrasound device set to 1 W/cm² in continuous mod

Sponsors

Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: Chronic or subacute myofascial back pain persisting for at least 4 weeks Pain score =4 on Numerical Pain rating scale (NPRS) Willingness to undergo ultrasound therapy and use the prescribed gel.

Exclusion criteria

Exclusion criteria: Dermatological issues or open wounds on the back Known allergies to any components of the gels Use of systemic corticosteroids or analgesicS Severe musculoskeletal conditions or neurological disorders

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 4 weeks. Method of measurement: NPRS.;Lumber ROM. Timepoint: 4 weeks. Method of measurement: Goniometry.;Muscle tenderness. Timepoint: 4 weeks. Method of measurement: Pressure pain threshold scale.

Secondary

MeasureTime frame
Serological findings. Timepoint: 4 weeks. Method of measurement: ESR, CRP,IL-6.;Quality of life. Timepoint: 4 weeks. Method of measurement: SF-36 scale.;Functional Status. Timepoint: 4 weeks. Method of measurement: McGill Questionnaire.

Countries

Pakistan

Contacts

Public ContactMaliha Khalid Khan

Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan.

malihatareen1997@gmail.com+92 333 6120602

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026